Associations among S100A4, Sphingosine-1-Phosphate, and Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease

• Published in: Oxidative medicine and cellular longevity Vol. 2022; no. 1; p. 6041471
• Main Authors: Qin, Hou-Ying, Li, Meng-Die, Xie, Guo-Fang, Cao, Wei, Xu, De-Xiang, Zhao, Hui, Fu, Lin
• Format: Journal Article
• Language: English
• Published: United States Hindawi 2022; John Wiley & Sons, Inc
• Subjects: Aged; Antibodies; Chronic obstructive pulmonary disease; Epithelial-Mesenchymal Transition; Female; Humans; Lung cancer; Lysophospholipids - metabolism; Male; Males; Metastasis; Neutrophils; Proteins; Pulmonary Disease, Chronic Obstructive - genetics; Pulmonary Disease, Chronic Obstructive - pathology; Pulmonary fibrosis; Respiratory Function Tests - methods; S100 Calcium-Binding Protein A4 - metabolism; Software; Sphingosine - analogs & derivatives; Sphingosine - metabolism; Statistical analysis; Tumors; Variables; United States > US
• ISSN: 1942-0900; 1942-0994; 1942-0994
• DOI: 10.1155/2022/6041471

Background. S100A4 is a member of the S100 calcium-binding protein family and is increased in patients with chronic obstructive pulmonary disease (COPD). Sphingosine-1-phosphate (S1P) is a naturally occurring bioactive sphingolipid, which regulates the adhesion between the cells and the extracellular matrix and affects cell migration and differentiation. The goal of this study was to analyze the correlations among S100A4, S1P, and pulmonary function among COPD patients. Methods. All 139 serum samples and 15 lung specimens were collected in COPD patients and control subjects. S100A4 and S1P were detected in two groups. The markers of fibrosis and epithelial-mesenchymal transition (EMT) were measured in the lungs of COPD patients and control subjects. Results. The protein expression of S100A4 was higher in the lungs and serum of COPD patients than control cases. Additionally, serum S100A4 was inversely associated with pulmonary function among COPD patients. Meanwhile, collagen deposition and EMT nuclear transcription factors were elevated in the lungs of COPD patients. Moreover, the protein expression of S1P was increased in the serum of COPD patients. Serum S1P was gradually increased along with pulmonary function decline in COPD patients. Further correlation analysis revealed that serum S1P was negatively associated with pulmonary function in COPD patients. Furthermore, there was a positive correlation between S1P and S100A4 in COPD patients. Conclusions. These results provide evidence that the elevation of S100A4 and S1P may be involved in the onset and progression of COPD.